Propofol or midazolam for short-term alterations in sedation.
It is often necessary to adjust a patient's sedation level while they are in the intensive care unit. The purpose of this study was to compare propofol with midazolam for controlling short-term alterations in sedation. Twenty-three patients undergoing an interactive procedure, physiotherapy, during mechanical ventilation of the lungs were studied. The patients were randomly assigned to receive infusions of propofol or midazolam for sedation. Sedation was assessed using the method of Ramsay, where 3 is drowsy responding only to commands; and 5 is asleep with a slow response to light glabellar tap. Prior to physiotherapy sedation was deepened from 3 to 5 by increasing the sedative infusion rate, and level 5 was maintained during physiotherapy by adjusting the infusion rate whenever necessary. After physiotherapy, the sedative dose was reduced until level 3 was again achieved. During physiotherapy, sedation level 5 was achieved for 53.9% of the time with propofol but for only 25.7% with midazolam (P < 0.01). After physiotherapy, those patients sedated with propofol re-awakened to level 3 faster (8.3 +/- 2.3 min, mean +/- SE) than those receiving midazolam (92.8 +/- 35.0 min, P < 0.05). After physiotherapy, a further 1.8 +/- 0.5 dose adjustments were required to the midazolam infusion while only 0.4 +/- 0.2 adjustments were required to the propofol infusion (P < 0.05). During physiotherapy 3.0 +/- 0.5 dose adjustments to the propofol dose were required compared with 3.6 +/- 0.5 adjustments to the midazolam dose (NS).(ABSTRACT TRUNCATED AT 250 WORDS)
Boyd
O
O
Division of Medicine, St. George's Hospital, London, UK.
Mackay
C J
CJ
Rushmer
F
F
Bennett
E D
ED
Grounds
R M
RM
D000368:Aged; D000771:Anesthesia, Intravenous; D001007:Anxiety / Q000175:diagnosis; D001794:Blood Pressure / Q000187:drug effects; D016292:Procedural Sedation; D003299:Cooperative Behavior; D004311:Double-Blind Method; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008874:Midazolam / Q000008:administration & dosage / Q000494:pharmacology; D026741:Physical Therapy Modalities; D011182:Postoperative Care; D015742:Propofol / Q000008:administration & dosage / Q000494:pharmacology; D011446:Prospective Studies; D012121:Respiration, Artificial; D012890:Sleep; D012894:Sleep Stages
D008874:Midazolam; D015742:Propofol